Home > Insider Trading > Filing (0001181431-10-005142)

Filing Details

Accession Number:: 0001181431-10-005142
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-01-28 12:00:00
Reporting Period:: 2010-01-27

Filing Date:: 2010-01-28
Accepted Time:: 2010-01-28 15:39:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1295976	Cellu Tissue Holdings Inc.	CLU	Paper Mills (2621)	061346495

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1306780	J David Morris	1855 Lockeway Drive Suite 501 Alpharetta GA 30004	Sr. V.p. Finance, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-01-27	19,737	$0.00	19,737	No	4	C	Direct
Common Stock	Acquisiton	2010-01-27	117,085	$0.00	136,822	No	4	C	Direct
Common Stock	Disposition	2010-01-27	44,427	$13.00	92,395	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2010-01-27	19,737	$0.00	19,737	$0.00
Common Stock	Common Stock	Disposition	2010-01-27	117,085	$0.00	117,085	$0.00
Common Stock	Employee Stock Option	Disposition	2010-01-27	120,932	$0.00	120,932	$5.28
Common Stock	Employee Stock Option	Acquisiton	2010-01-27	120,932	$0.00	120,932	$5.28
Common Stock	Employee Stock Option	Acquisiton	2010-01-27	28,225	$0.00	28,225	$11.45

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Direct
0		No	4	C	Direct
0	2019-04-13	No	4	J	Direct
120,932	2019-04-13	No	4	J	Direct
28,225	2020-01-27	No	4	A	Direct

Footnotes

Series B Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
Reporting person was granted shares of Restricted Stock in Cellu Parent Corporation on August 6, 2007, of which 50% had vested. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering and upon the closing of the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation Common Stock was exchanged for fully vested shares of Issuer Common Stock.
Reporting person held an option to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
On the date of the exchange, options to purchase 39,267 shares became fully vested and options for the remaining shares will vest as to 33.33% of the shares each year beginning on the first anniversary date of the closing of the Issuer's initial public offering.
Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.